Concepedia

Publication | Open Access

Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis

37

Citations

9

References

2020

Year

Abstract

<b>Benralizumab reduces oral corticosteroid requirements in patients with EGPA and leads to improved patient-reported outcome measures</b> https://bit.ly/2GI0vhf.

References

YearCitations

Page 1